The PAPPA2 gene helps release growth signals so children’s bones and tissues can grow in a steady way. If it does not work properly, the body may hold on to these signals instead of using them, which can lead to slower growth, short stature, and lower weight gain in childhood. The protein made by this gene helps your cells make insulin-like growth factors more available, especially during growth. Changes in both copies of the PAPPA2 gene are linked to a rare inherited growth condition.

What is a gene?

A gene is a stretch of DNA that carries instructions cells use to make molecules or regulate activities in the body. Some genes provide the directions for producing proteins, which are the functional parts of cells. Others are mainly involved in controlling when certain processes happen, where they take place, and how active they are. In combination, genes affect how the body grows and works, and they may shape how you respond to food, stress, or medicines. For a more detailed explanation of this topic, you can find more in the LearnHub.

Overview

PAPPA2

Gene function

What if the gene works

The PAPPA2 gene helps release growth signals from carrier proteins in the blood. This supports normal bone growth and overall height during childhood and adolescence.

Risk

What if the gene does not work

Variants in the PAPPA2 gene can impair growth after birth, often leading to short stature and sometimes lower bone density. Milder to more severe variants may affect how early growth slows and how marked these features become.

Treatment

What does that mean for your treatment

No PAPPA2-specific treatment or drug selection approach is currently established in clinical guidelines. In research settings, some people with pathogenic variants in the PAPPA2 gene have received recombinant IGF-1 to try to improve growth, but this remains an emerging specialist approach rather than a standard PAPPA2-directed treatment.

Gene function

What if the gene works

Growth depends on signals being released at the right time and place. The PAPPA2 gene helps control that timing by making a protein that works outside cells. Its main job is to adjust how much of certain growth signals are available to tissues. This helps explain how the PAPPA2 gene supports growth in the body.

Growth signal release

PAPPA2 helps free insulin-like growth factors, or IGFs (growth signals), from proteins that hold them in reserve. This lets more of those signals reach nearby cells when needed.

Protein cutting

Its protein acts as an enzyme (a protein that cuts other proteins) outside cells. It mainly cuts IGFBP-3 and IGFBP-5, two proteins that carry and restrain IGFs.

Signal balance

By controlling how much IGF is available locally, PAPPA2 fine tunes communication between tissues and growth signals. This supports steady growth and normal tissue development.

What is a variant?

Within a gene, a genetic variant is a slight change in its DNA sequence. These changes are common and help explain normal differences among people, such as appearance, metabolism, or the way the body responds to environmental influences. Many have no noticeable effect and are simply part of natural genetic variation. In some cases, though, a variant changes how a gene works more substantially and may contribute to or cause a genetic condition.

Variant illustration

Genetic variants

What if the gene does not work

Variants in the PAPPA2 gene can weaken or shut down the protein's protein-cutting activity, so growth signals stay tightly bound to carrier proteins and are less available to tissues. How PAPPA2 gene variants affect protein function depends on the change: some reduce folding, stability, or release from the cell, while more disruptive variants can nearly abolish enzyme activity. In people with two severe variants, growth-related features often appear earlier and are more pronounced than with milder changes.

How variants are linked to conditions

Pathogenic variants in the PAPPA2 gene cause a rare inherited growth condition marked by slower growth after birth and short stature. In families described with PAPPA2 gene variants linked to short stature, affected children may also have lower bone density and thinner bones on imaging. This is a genetic diagnosis when disease-causing variants are found in both copies of the gene. The condition is rare, so symptoms and severity can vary from person to person.

A variant is not necessarily a diagnosis

Genetic variants are a usual part of human biology and are widely found in the general population. Most do not have a direct effect on health and simply reflect natural human diversity. For many genes, carrying a variant associated with a condition indicates a possible link rather than a definite diagnosis, especially when several genes and environmental factors play a role. In some situations, however, a single well-characterized variant in a specific gene can be enough to confirm a diagnosis.

Dr. Wallerstorfer Dr. Wallerstorfer

Are there things that can increase or change my risk?

There is not yet broadly confirmed evidence on specific factors that increase or reduce risk related to the PAPPA2 gene. For many living with a PAPPA2 change, risk mainly depends on the exact genetic change inherited in the family, and a doctor or genetic counselor can help explain personal risk.

Inheritance of PAPPA2 variants

PAPPA2-related conditions are inherited in an autosomal recessive pattern. This means a child usually inherits one PAPPA2 gene variant from each parent, and the parents are often healthy carriers. When both parents carry a variant in the PAPPA2 gene, each pregnancy has a 25% chance of being affected, a 50% chance of resulting in a carrier child, and a 25% chance of inheriting neither variant. This is the main pattern seen when explaining how PAPPA2 gene variants are inherited.

What does my PAPPA2 result mean for my family?

For families with a disease-causing PAPPA2 result linked to the known growth condition, the pattern is recessive, which usually means parents are healthy carriers and brothers or sisters may also be affected or be carriers. Other close relatives, such as siblings of the parents, may also carry the family variant. Family testing can help clarify who else in the family may have the same result.


Genetic information


Genetic testing

How you find out about variants

To look for changes in the PAPPA2 gene, doctors use PAPPA2 genetic testing on a blood or saliva sample. A lab reads the gene's DNA sequence, and sometimes checks for missing or extra pieces, to see whether a variant is present and whether the result may help explain growth concerns.

When should I consider getting a genetic test?

Testing for the PAPPA2 gene may be worth considering when a child has marked slow growth or is much shorter than expected for age without a clear cause, especially if similar growth problems run in the family. A PAPPA2 change can help explain a rare inherited growth condition and guide follow-up care.

A genetic result is only one part of your health story

A genetic finding can provide meaningful insight, but what it can tell you varies based on the condition and the type of variant involved. Many factors, including lifestyle, environment, age, and medical history, shape how the body works over time. For some conditions, especially those influenced by many genes, genetic information provides context rather than certainty and is most useful when considered alongside other parts of care. In other situations, a genetic result may give a clear answer. In areas such as medication response, genetic results can also help put individual experiences into context.

Dr. Wallerstorfer Dr. Wallerstorfer

Pharmacogenetics

How variants shape your response to medicine

Genetic variation can affect how people respond to medicines. Some people break down a drug more quickly, while others process it more slowly or are more sensitive to its effects. This helps explain why the same treatment can work well for one person but cause fewer benefits or more side effects for another. These differences are common and are one part of how the body handles medication.

What is Pharmacogenetics?

Pharmacogenetics examines how differences in genes affect the way people respond to medicines. It studies patterns between genes and drugs to help explain why the same treatment may work differently from one person to another. For many medicines, genes influence both how strongly a drug works and how the body processes it. This information can support more informed, more individualized treatment decisions. To explore this topic in more detail, visit the LearnHub.


Drugs influenced by the PAPPA2 gene

There are 0 Drugs associated with PAPPA2
Currently no available information

When should I seek medical advice?

There is not yet a broadly confirmed role for this gene in how medicines work, so any concerns about side effects, new symptoms, or whether a treatment is right for you are best discussed with your doctor.

DISCLAIMER: The materials present on Genopedia.com, such as text, images, graphics, among other items (“Content”), are shared purely for informational reasons. This content should not replace professional health advice, medical diagnoses, or treatment procedures. Whenever you have health concerns or questions, it’s always recommended to engage with your doctor or another appropriate healthcare provider. If you read something on the Genopedia.com site, do not neglect professional medical counsel or delay in obtaining it. In case you believe you’re dealing with a medical crisis, get in touch with your medical professional or call emergency without delay. Genopedia.com doesn’t advocate for any particular medical tests, healthcare providers, products, methods, beliefs, or other data that could be discussed on the site. Please also note that the content, originally written in English and in part created with the help of artificial intelligence, is provided without any warranty, and any reliance on information offered by Genopedia.com, its staff, contributors invited by Genopedia.com, or site users is entirely at your own risk.
Genopedia © 2026 all rights reserved